These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3098653)

  • 1. [Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug. (3) Damaging effects on the gastrointestinal tract].
    Ono N; Yamasaki Y; Yamamoto N; Sunami A; Miyake H
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):205-13. PubMed ID: 3098653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug. (2). Analgesic and antipyretic effects].
    Ono N; Sunami A; Yamamoto N; Yamasaki Y; Miyake H
    Nihon Yakurigaku Zasshi; 1986 Aug; 88(2):77-84. PubMed ID: 3490420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug (4). Mode of action on anti-inflammatory activity.
    Ono N; Yamasaki Y; Yamamoto N; Sunami A; Miyake H
    Jpn J Pharmacol; 1986 Nov; 42(3):431-9. PubMed ID: 3102823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug. (1). Anti-inflammatory effects].
    Ono N; Yamamoto N; Sunami A; Yamasaki Y; Miyake H
    Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):33-46. PubMed ID: 3758875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of indomethacin and proglumetacin on 6-oxo-PGF1 alpha released ex vivo by rat gastric mucosa.
    Conti P; Alesse E; Cifone MG
    Int J Tissue React; 1986; 8(1):31-4. PubMed ID: 3512465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal lesions induced in the rat intestinal tract by the anti-inflammatory drug, Wy-41,770, a weak inhibitor of prostaglandin synthesis, contrasted with those from the potent prostaglandin inhibitor, indomethacin.
    Rainsford KD
    Toxicol Pathol; 1988; 16(3):366-75. PubMed ID: 3143146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indometacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat.
    Weissenborn U; Maedge S; Buettner D; Sewing KF
    Pharmacology; 1985; 30(1):32-9. PubMed ID: 3975254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological activity and toxicity of apyramide: comparison with non-steroidal anti-inflammatory agents.
    Sauvaire D; Michel A; Serrano JJ; Richard M
    Drugs Exp Clin Res; 1987; 13(5):247-52. PubMed ID: 3500027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atropine-induced gastrointestinal cytoprotection dependences to the intact of vagal nerve against indomethacin-induced gastrointestinal mucosal and microvascular damage in rats.
    Karádi O; Nagy Z; Bódis B; Mózsik G
    J Physiol Paris; 2001; 95(1-6):29-33. PubMed ID: 11595415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of stress preconditioning on vulnerability of gastric and small intestinal mucosa to ulcerogenic action of indomethacin in rats.
    Yarushkina NI; Filaretova LP
    J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32084648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morin protects gastric mucosa from nonsteroidal anti-inflammatory drug, indomethacin induced inflammatory damage and apoptosis by modulating NF-κB pathway.
    Sinha K; Sadhukhan P; Saha S; Pal PB; Sil PC
    Biochim Biophys Acta; 2015 Apr; 1850(4):769-83. PubMed ID: 25603542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulnerability of gastric and small intestinal mucosa to ulcerogenic action of indomethacin in C57/BL6/J mice and transient receptor potential channel vanilloid type 1 knockout mice.
    Yarushkina NI; Sudalina MN; Punin YM; Filaretova LP
    J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of salicylates and other non-steroidal anti-inflammatory agents in rats as shown by gastro-ulcerogenic and anti-inflammatory activities, and plasma concentrations.
    Corell T; Jensen KM
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):225-31. PubMed ID: 506746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Irritative effects of acemetacin and indomethacin on the gastrointestinal tracts of rats (author's transl)].
    Nakamura M; Yoshinaka Y; Suzuki H; Wada Y
    Nihon Yakurigaku Zasshi; 1981 Nov; 78(5):511-9. PubMed ID: 7327463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of proglumetacin maleate and its major metabolites on allergic air pouch inflammation in rats.
    Ono N; Sunami A; Yamasaki Y; Yamamoto N; Miyake H
    Eur J Pharmacol; 1987 Oct; 142(2):245-51. PubMed ID: 2826180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of indomethacin and aspirin or mepirizole in rats as shown by gastrointestinal ulcerogenic and anti-inflammatory activities.
    Tsurumi K; Kyuki K; Fujimura H
    J Pharmacobiodyn; 1980 Dec; 3(12):659-66. PubMed ID: 7277181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic oral toxicity study of proglumetacin maleate in beagle dogs].
    Imoto S; Aoki M; Shimpo K; Yamashita K
    J Toxicol Sci; 1987 Feb; 12 Suppl 1():1-33. PubMed ID: 3573082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcerogenic and antiulcerogenic effects of a new antiinflammatory drug, the gamma-lactone-N-ethyl derivative of 6-[1S-(3S,4-dihydro-8-hydroxy-1H-2-benzo- pyran-1-one-3-yl)-3-methylbutylamino]-4S,5S-dihydroxy-6-oxo-3S- ammoniohexanoate, on gastrointestinal tract in rats.
    Urushidani T; Kasuya Y; Yano S
    Arzneimittelforschung; 1986 Sep; 36(9):1383-90. PubMed ID: 3790191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.